Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Global health

Roche initiative seeks to expand access to HIV viral load tests

An initiative by Roche to slash prices for its HIV viral load test in developing countries will boost access to the test, used to monitor the effects of antiretroviral drug therapy, according to UNAIDS.

“The new initiative creates a ceiling price of US$9.40 per test, and will reduce Roche’s average price by more than 40%,” the organisation said after the initiative was announced on 25 September 2014 during a panel on AIDS held on the sidelines of the UN General Assembly in New York.

Roche has committed to expanding access to its AmpliPrep/COBAS TaqMan HIV–1 Test version 2.0 through a special pricing scheme in eligible countries.

Alan Staple, head of global markets at the Clinton Health Access Initiative (CHAI), which helped broker the Roche scheme, said that about 4 million viral load tests are done in developing nations, including 2.5 million in South Africa. “We expect that total to grow to over 11 million by the end of 2017,” he said.

High prices have been a major factor in why less than 25% of people on antiretroviral therapy currently have access to the tests, UNAIDS said.

CHAI’s Staple said there is no standard pricing for the tests, which are sold by Roche, Abbott and BioMerieux at prices ranging from US$10.50 to US$60 in low and middle income countries. “We believe the weighted average price outside of South Africa to be about US$20 per test.”

Sharonann Lynch, HIV/TB adviser for Médecins Sans Frontières (MSF), added: “Affordable tests have been the missing piece to detecting and preventing HIV treatment failure.” 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066688

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • MCQs in Clinical Pharmacy

    MCQs in Clinical Pharmacy

    Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.

    £25.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.